tiprankstipranks
Trending News
More News >
Pure Bioscience (PURE)
OTHER OTC:PURE
US Market

Pure Bioscience (PURE) Income Statement

Compare
44 Followers

Pure Bioscience Income Statement

Last quarter (Q1 2026), Pure Bioscience's total revenue was $708.00K, an increase of 27.34% from the same quarter last year. In Q1, Pure Bioscience's net income was $-464.00K. See Pure Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.20B$ 1.96M$ 1.88M$ 1.85M$ 3.93M
Gross Profit
$ 1.30B$ 1.15M$ 971.00K$ 1.00M$ 2.08M
Operating Expenses
$ 3.58B$ 4.34M$ 4.60M$ 4.42M$ 4.39M
Depreciation and Amortization
$ 2.00K$ 148.00K$ 117.00K$ 213.00K$ 172.00K
EBITDA
$ -2.10M$ -3.05M$ -3.83M$ -3.27M$ -2.14M
Operating Income
$ -2.27M$ -3.13M$ -3.94M$ -3.42M$ -2.31M
Other Income/Expenses
$ -127.00K$ -219.00K$ -18.00K$ 233.00K$ -8.00K
Pretax Income
$ -2.40M$ -3.35M$ -3.96M$ -3.49M$ -2.32M
Net Income
$ -2.40M$ -3.35M$ -3.96M$ -3.50M$ -2.32M
Per Share Metrics
Basic EPS
$ -0.02$ -0.03$ -0.04$ -0.04$ -0.03
Diluted EPS
$ -0.02$ -0.03$ -0.04$ -0.04$ -0.03
Weighted Average Shares Outstanding
111.86M 111.86M 111.40M 88.84M 87.17M
Weighted Average Shares Outstanding (Diluted)
111.86M 111.86M 111.40M 88.84M 87.17M
Currency in USD

Pure Bioscience Earnings and Revenue History